SCHEMBL19781814

SCHEMBL19781814

CC(C)(C)C1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O

nearest known ligand 0.62

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 1/20 0.53
▸ MEN1 O00255 2/20 0.51
▸ KMT2A Q03164 2/20 0.51
▸ MAPT P10636 1/20 0.51
▸ LGALS8 O00214 1/20 0.50
▸ LGALS3 P17931 1/20 0.50
▸ LGALS4 P56470 1/20 0.50
▸ GJA1 P17302 1/20 0.46
▸ GJB2 P29033 1/20 0.46
▸ CYP2C9 P11712 1/20 0.46
▸ TSHR P16473 1/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ IGF2R P11717 2/20 0.45
▸ AMY1A P0DUB6 1/20 0.44
▸ POLB P06746 1/20 0.43
▸ PTPN1 P18031 1/20 0.43
▸ LMNA P02545 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25140877 1.00 L3MBTL1 (0.53) L3MBTL1MEN1KMT2AMAPTLGALS8
SCHEMBL16263450 1.00 L3MBTL1 (0.53) L3MBTL1MEN1KMT2AMAPTLGALS8
SCHEMBL25140766 1.00 L3MBTL1 (0.53) L3MBTL1MEN1KMT2AMAPTLGALS8
SCHEMBL25140770 0.95 L3MBTL1 (0.50) L3MBTL1MEN1KMT2AMAPTLGALS8
SCHEMBL25705577 0.94 L3MBTL1 (0.48) L3MBTL1MEN1KMT2AMAPTLGALS8
SCHEMBL25705581 0.94 L3MBTL1 (0.48) L3MBTL1MEN1KMT2AMAPTLGALS8
SCHEMBL19769974 0.94 L3MBTL1 (0.48) L3MBTL1MEN1KMT2AMAPTLGALS8
SCHEMBL25140762 0.94 LGALS3 (0.51) L3MBTL1MEN1KMT2AMAPTLGALS8
SCHEMBL19782039 0.92 L3MBTL1 (0.51) L3MBTL1MEN1KMT2AMAPTLGALS8
SCHEMBL25692868 0.92 L3MBTL1 (0.51) L3MBTL1MEN1KMT2AMAPTLGALS8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180016291-A1 Rebaudioside Analogs PEPSICO, INC. 2018-01-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180016291-A1 Rebaudioside Analogs SLC5A1, TAS1R1, FBP1 L3MBTL1 2417/4885MEN1 475/4885KMT2A 2884/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback